It is of note that among these immune checkpoints, PD-L1 expression in NSCLC is upregulated by oncogenic activation of the AKT-mTOR pathway and mTOR-mediated IFN-γ expression [121]. This evidence concerns the gene MTOR and non-small cell lung carcinoma.